Israel: Peregrine Ventures closes fourth fund at US$115m

Eyal Lifschitz, managing partner, Peregrine

Leading Israeli med-tech venture capital fund Peregrine Ventures has closed its fourth fund, Peregrine 4, at US$115m million. It said that partners include some of the leading institutional and private equity investors from Israel, the US, Europe and Australia. Peregrine 4 will continue to invest in early stage and late stage rounds of medical technology…

You must be a HMI Subscriber to view this content.

Subscribe Now »